Navigation Links
Multiple infectious disease strains can coexist

A study has thrown light on the observation that multiple infectious disease strains can coexist. This has been explained in the August issue of The American Naturalist//, where Ken Eames and Matt Keeling (University of Warwick) have demonstrated with the help of a mathematical model, the coexistence of multiple strains of infectious diseases and their behavior and response to human interaction, which is abetted by monogamous behavior in the population.

"When people are serially monogamous (that is, interactions take place one at a time), groups with different behavior favor strains with different properties," explain the authors. "When new interactions occur frequently, rapidly transmitted strains are most successful, but when new interactions take place infrequently there is extra pressure on strains to have a long infectious period."

Eames and Keeling focused their study on sexually transmitted infections, where the assumption of monogamy is most applicable, but stress that their conclusions may have wider relevance.

"There are implications for all sorts of other infections too," Eames continues. "Just think of the behavioral differences between village and city life: one with quiet streets and few new faces, and the other with thousands of hurrying people and crowded public transport. That's two very different environments for a pathogen. There are always going to be plenty of factors that determine which strains emerge, but human mixing behavior has a big part to play."

Source : Eureka Alert
'"/>




Page: 1

Related medicine news :

1. Naked DNA Vaccination May Conquer Arthritis and Multiple Sclerosis
2. Multiple organ disease cured by genes
3. Adult stem cells in treatment for Multiple sclerosis (MS)
4. Life Quality For Patients With Multiple Sclerosis
5. Effective Pain Relief For Patients Suffering From Multiple Sclerosis
6. The Link Between Hepatitis B Vaccine And Multiple Sclerosis Questioned
7. Hope For Patients With Multiple Sclerosis
8. Individuals Born In May At A Higher Risk Of Developing Multiple Sclerosis
9. Debating The Link Between Sex Hormones And Multiple Sclerosis
10. Warning Issued by FDA on consumption of the drug Tysabri used to treat Multiple Sclerosis
11. Decreasing Multiple Births By Single Embryo Transfers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/17/2017)... ... February 17, 2017 , ... ... educational assistance management solution to the exhibit floor for the 2017 HIMSS ... , From Feb. 19–23, 2017, more than 40,000 healthcare industry professionals are ...
(Date:2/17/2017)... ... February 17, 2017 , ... Empowering each person's mental ... for each and every seminar, session and class she offers. At the ... tools which help energize creativity, focus mental functions, enhance athletic focus and skill ...
(Date:2/17/2017)... ... February 17, 2017 , ... Qualis Health, one of ... the 8th Annual DecisionHealth Platinum Awards in recognition of its innovative healthcare management ... recognized across multiple award categories, highlighting four of the organization’s current programs:, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Program ... , Trinity Health and the U.S. Soccer Foundation announced today that they have ... communities. Soccer for Success, the Foundation’s soccer mentoring program, teaches kids the fundamentals ...
(Date:2/17/2017)... ... 2017 , ... Pharmica Consulting attended CHI's 8th Annual SCOPE ... trial planning and management. Pharmica discussed the importance of effective project management, data ... by Pharmica’s booth were able to demo its cloud-based Resource Management Tool, ...
Breaking Medicine News(10 mins):
(Date:2/19/2017)... 19, 2017  nThrive™, an independent Patient-to-Payment? solutions ... thought leadership at the 2017 HIMSS Conference. The ... award from KLAS. nThrive will host ... how market trends shape the holistic, integrated revenue ... comprehensive Patient Access solution. The panel will reveal ...
(Date:2/18/2017)... HILL, N.C. , Feb. 17, 2017  Pharmaceutical companies ... insights about products either in development or already on the ... have forced the pharma industry to alter how it manages ... boards, consulting leader Best Practices, LLC conducted a new study ... ...
(Date:2/17/2017)... Feb. 17, 2017 Theravance Biopharma, Inc. ... the "Company") today announced the presentation of positive ... orally administered pan-Janus kinase (JAK) inhibitor designed to ... Congress of the European Crohn,s and Colitis Organization ... further data from its completed Phase 1 study ...
Breaking Medicine Technology: